HESI

  

ILSI HESI's New Address

1156 15th Street N.W.
Second Floor
Washington, DC 20005
USA

 

 

Home Page

MEMBER LOGIN

Not registered?
Register here!

CONTACT US

by email:
hesi@hesiglobal.org

by phone:
202-659-3306 tel
202-659-3617 fax

by mail:
One Thomas Circle, NW
9th Floor
Washington, DC 20005-5802
USA



To connect to the
ILSI home page
click here.

2008 EMERGING ISSUES - REQUEST FOR PRIORITIZATION

  • Deadline:  Friday, February 22, 2008
  • Click here to download the prioritization (voting) form. 
  • Return the form to Cyndi Nobles (HESI) by fax at 202-659-3617.
  • Voting is not restricted.  HESI encourages votes from government, academia, and industry.  Multiple votes from a single institution will be combined and/or weighted as appropriate.

Each year, HESI seeks broad input on emerging scientific issues that merit consideration for potential program development.  In 2007, HESI conducted its annual survey for emerging scientific issues.  From this survey, the HESI Emerging Issues Steering Committee (EISC) selected four topics for consideration in 2008.  These topics were presented at the January 2008 HESI Annual Meeting in Puerto Rico (see below).  After the voting deadline, the EISC will determine which topic warrants sufficient interest to initiate a subcommittee within the HESI scientific portfolio.


TOPICS FOR CONSIDERATION IN 2008

Risk to Human and Ecological Health from Pharmaceuticals in the Environment

  • Click here for a summary of the topic.
  • Click here for a presentation by Dr. Hal Zenick, US EPA National Health and Environmental Effects Research Laboratory.  

Distinguishing Adverse from Adaptive, Non-functional and Pharmacological Changes in Toxicology Studies

  • Click here for a summary of the topic. 
  • Click here for a presentation by Dr. William Farland, Colorado State University.
  • Click here for a presentation by Dr. Douglas Keller, sanofi-aventis. 
     

    Establishing Acceptable Exposure Limits for Intermittent or Short-Term Exposure to Carcinogens

    • Click here for a summary of the topic.
    • Click here for a presentation by Dr. Susan Felter, The Procter & Gamble Company.
    • Click here for a presentation by Dr. Gary Williams, New York Medical College.

    Drug Abuse Liability / Preclinical Abuse Liability Assessment

    • Click here for a summary of the topic.
    • Click here for a presentation by Dr. S. Stevens Negus, Virginia Commonwealth University.
    • Click here for a presentation by Dr. Mary Jeanne Kallman, Eli Lilly & Company.

    If you have questions or comments about the specific topics under consideration and/or the HESI Emerging Issue Process in general, please contact:


    Nancy G. Doerrer, MS
    HESI Senior Scientific Program Manager
    PH:  202-659-3306
    Email:  ndoerrer@hesiglobal.org